Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know. Labcorp met analysts’ revenue ...

Oct 24 (Reuters) - Laboratory operator Labcorp (LH.N), opens new tab beat Wall Street estimates for third-quarter profit and revenue on Thursday as strong demand for diagnostic tests offset a hit from ...

(1) 2025 Updated guidance includes an impact from foreign currency translation of 0.4%. (2) Enterprise level revenue is presented net of intersegment transaction eliminations. (3) 2025 Updated ...

Labcorp Holdings Inc. LH, or Labcorp, is positioning itself for sustained growth with a series of strategic acquisitions and partnerships. With a growing emphasis on cell and gene therapy, the company ...

Labcorp Holdings Inc. LH, or Labcorp, is prioritizing key specialty testing areas, such as oncology, women’s health, autoimmune disease and neurology, aiming to tap into strong growth opportunities.

Labcorp delivered mixed third-quarter results, with higher sales and raised profit guidance but a lower full-year revenue forecast as it “takes action” on an underperforming unit. First, overall sales ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...

Restructuring and other charges represent amounts incurred in connection with the elimination of redundant positions and facilities and contract termination costs within the organization in connection ...